[HTML] mdpi.com

[HTML][HTML] Immune responses following locoregional treatment for hepatocellular carcinoma: possible roles of adjuvant immunotherapy

JW Han, SK Yoon - Pharmaceutics, 2021 - mdpi.com
Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide.
Unlike other types of cancer, HCC can be treated with locoregional treatments (LRTs) such …
被引用次数：19 相关文章

Immune responses following locoregional treatment for hepatocellular carcinoma: Possible roles of adjuvant immunotherapy

JW Han, SK Yoon - Pharmaceutics, 2021 - cuk.elsevierpure.com
Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide.
Unlike other types of cancer, HCC can be treated with locoregional treatments (LRTs) such …

Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy

JW Han, SK Yoon - Pharmaceutics, 2021 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide.
Unlike other types of cancer, HCC can be treated with locoregional treatments (LRTs) such …

Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy

H Ji-Won, SK Yoon - Pharmaceutics, 2021 - search.proquest.com
Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide.
Unlike other types of cancer, HCC can be treated with locoregional treatments (LRTs) such …

Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy.

JW Han, SK Yoon - Pharmaceutics, 2021 - search.ebscohost.com
Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide.
Unlike other types of cancer, HCC can be treated with locoregional treatments (LRTs) such …
[HTML] nih.gov

[HTML][HTML] Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy

JW Han, SK Yoon - Pharmaceutics, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide.
Unlike other types of cancer, HCC can be treated with locoregional treatments (LRTs) such …

Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy.

JW Han, SK Yoon - Pharmaceutics, 2021 - europepmc.org
Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide.
Unlike other types of cancer, HCC can be treated with locoregional treatments (LRTs) such …